Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

The China Fund, Inc. (CHN)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
13.30+0.02 (+0.15%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close13.28
Open13.26
Bid12.10 x 1400
Ask15.76 x 800
Day's Range13.12 - 13.38
52 Week Range12.00 - 28.50
Volume8,636
Avg. Volume16,006
Market Cap137.018M
Beta (5Y Monthly)0.45
PE Ratio (TTM)12.31
EPS (TTM)1.08
Earnings DateMar 16, 2021
Forward Dividend & Yield0.04 (0.32%)
Ex-Dividend DateDec 27, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CHN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • China Fund, Inc. (The)
    Analyst Report: Dr. Reddy's Laboratories LimitedHeadquartered in India, Dr. Reddy’s Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the company’s sales are well dispersed across North America, India, and other emerging markets.
    Rating
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more
  • PR Newswire

    The China Fund, Inc. Announces Date of Annual Meeting of Stockholders

    The China Fund, Inc. (NYSE: CHN) (the "Fund") announced today that the Fund's annual stockholder meeting (the "Meeting") will be rescheduled for Tuesday, May 3, 2022 via a virtual forum at 11:00 a.m. Stockholders of record as of February 19, 2022 will be entitled to notice of, and to attend and vote at, the Meeting. The notice for the Meeting will be mailed to shareholders on or about March 30, 2022. This notice supersedes all previous notifications related to the Fund's Meeting.

  • PR Newswire

    The China Fund, Inc. Announces Postponement of Annual Meeting of Stockholders

    The China Fund, Inc. (NYSE: CHN) (the "Fund") announced on March 21, 2022, that the Fund's annual stockholder meeting scheduled to be held on March 23, 2022, will be postponed, until further notice, to ensure materials mailed to shareholders contain all necessary and relevant information. A new record date for determining the shareholders entitled to notice of, and to attend and vote at the meeting will be established and announced in the coming weeks.

  • PR Newswire

    THE CHINA FUND, INC. RECORDS FIRST QUARTER 2021/2022 RESULTS

    The China Fund, Inc. (NYSE: CHN) today announced its financial results for its first fiscal quarter ended January 31, 2022.

Advertisement
Advertisement